Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

More Than 200 Potential Jurors Excused from Shkreli’s Trial

By Meg Snyder | August 17, 2017

The former CEO of Retrophin and Turing Pharmaceuticals, Martin Shkreli—famous for raising the price of Daraprim by 5,000 percent—was convicted of three counts of fraud in federal court earlier this month.

According to The New York Times: “[A]fter five days of deliberations, jurors convicted him on three counts of fraud in federal court, and he now faces up to 20 years in prison on each of the first two counts, and up to five years on the final count.”

The convicted charges, as detailed in The New York Times article, include:

  1. “[S]ecurities fraud in connection with his hedge fund MSMB Capital”
  2. “[S]ecurities fraud in connection with MSMB Healthcare”
  3. “[C]onspiracy to commit securities fraud related to the Retrophin stock scheme”

Seeming to embrace the verdict, sources claim Shrkeli said he was “delighted” and that it was “a witch hunt of epic proportions.”

“Later in the afternoon,” according to a The New York Times article, “he was live-streaming once more, sipping beer and joking about prison life from his Manhattan apartment.”

Yesterday, Harper’s Magazine published transcripts of the jury selection from the trial, taking place over three days in June. The jurors were united one thing: Their dislike of Shkreli.

Below are excerpts:

The Court: The purpose of jury selection is to ensure fairness and impartiality in this case. If you think that you could not be fair and impartial, it is your duty to tell me. All right. Juror Number 1.

Juror No. 1: I’m aware of the defendant and I hate him. 

. . . 

The Court: Juror Number 1 is excused. Juror Number 18.

Juror No. 18: Both of my parents are on prescriptions that have gone up over the past few months, so much that they can’t afford their drugs. I have several friends who have H.I.V. or AIDS who, again, can’t afford the prescription drugs that they were able to afford.

The Court: These charges don’t concern drug pricing. Could you decide this case based only on the evidence —

Juror No. 18: No. No.

The Court:  — presented at this trial and put aside anything you might have heard in the media?

Juror No. 18: No. No.

The Court: Sir, we are going to excuse you from this panel. Juror Number 25, come forward, please.

And on and on it goes.  

“I’m feeling great, doing great,” Shkreli said in an interview with Fox. Found guilty of three of eight federal criminal charges, Shkreli continues to hold to his confidence, adding that he doesn’t think he’ll have to “forfeit any money.”

(Sources: The New York Times, Harper’s Magazine, CNBC, Fox)

Photo credit: AP, Seth Wenig.

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE